annb0t
Top 20
Key Insights
The projected fair value for AFT Pharmaceuticals is NZ$3.31 based on 2 Stage Free Cash Flow to Equity Current share price of NZ$3.80 suggests AFT Pharmaceuticals is potentially trading close to its fair value Our fair value estimate is 21% lower than AFT Pharmaceuticals' analyst price target of NZ$4.17
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of AFT Pharmaceuticals Limited (NZSE:AFT) as an investment opportunity by estimating th...
>>> Read more: Estimating The Fair Value Of AFT Pharmaceuticals Limited (NZSE:AFT)
The projected fair value for AFT Pharmaceuticals is NZ$3.31 based on 2 Stage Free Cash Flow to Equity Current share price of NZ$3.80 suggests AFT Pharmaceuticals is potentially trading close to its fair value Our fair value estimate is 21% lower than AFT Pharmaceuticals' analyst price target of NZ$4.17
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of AFT Pharmaceuticals Limited (NZSE:AFT) as an investment opportunity by estimating th...
>>> Read more: Estimating The Fair Value Of AFT Pharmaceuticals Limited (NZSE:AFT)
